POPULARITY
Categories
In this episode, Cathleen McCabe, MD, and Laura Enyedi, MD, chat with guest Erin M. Shriver, MD, FACS, an ophthalmologist and clinical professor of ophthalmology and visual sciences and the Jim O'Brien Gross and Donnita Gross Chair of Ophthalmology at the University of Iowa, about how we can better advocate for patients. ● Welcome to this episode 0:11 ● Introducing Erin M. Shriver, MD, FACS 0:35 ● Tell us a little bit about where you are now and how you got there 1:45 ● Choosing to look at advocacy and public health issues 5:36 ● Research on intimate partner violence 6:15 ● Do you think doing surgery is giving patients/women control over their body? 9:20 ● The Intimate Partner Violence Toolkit 10:08 ● Speaking on sensitive topics with patients 10:51 ● Your new role of Vice Chair of Faculty Affairs 11:31 ● Having standardized metrics 13:54 ● Gender disparities 14:21 ● Global mentorship of other women ophthalmologists 16:06 ● Stronger together, virtually and globally 19:40 ● The importance of listing 'being a mom' on your CV 20:20 ● Thank you! 24:24 Laura Enyedi, MD, is a professor of ophthalmology and pediatrics at Duke Eye Center and medical director of South Durham Ophthalmology in North Carolina. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, Florida. Erin M. Shriver, MD, FACS, an ophthalmologist and a clinical professor of ophthalmology and visual sciences and the Jim O'Brien Graoss and Donnita Gross Chair of Ophthalmology at the University of Iowa. Find the Intimate Partner Violence Toolkit here. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Disclosures: The hosts and guests report no relevant financial disclosures.
Elevating professionalism is key to much of the day-to-day work of Ellen M. Friedman, MD, FACS, FAAP, and we knew we had to have her join the Faculty Factory Podcast to learn more. Dr. Friedman serves as Professor of Otolaryngology-Head & Neck Surgery and is the Senior Associate Dean of Professionalism and the Director of the Center for Professionalism at Baylor College of Medicine in Houston. The end result of the Center for Professionalism, which we discuss at length in today's episode, is a warm and positive professional climate at Baylor College of Medicine. We also dive into the concept of professionalism in general. More about the Center: https://www.bcm.edu/education/academic-faculty-affairs/center-for-professionalism While promoting professionalism is the core service of the Center, it also has systems in place to report instances where professionalism is lacking. The problem with traditional wellness programs is that they often place the burden on the individual while systematic issues at the institution remain unresolved, as Dr. Friedman points out. The Center at Baylor aims to address those systematic issues so they don't stand in the way of wellness and progress. More than anything else, however, the Center exists to acknowledge and recognize acts of positive professionalism. “It's a very small number of individuals who are perceived to have lapses in professionalism, but unfortunately, that small group of people tends to receive the most attention,” she says. For that reason, the Center is dedicated to honoring professionals who demonstrate exemplary professionalism. More resources: https://facultyfactory.org/
This episode features C. William Schwab, MD, FACS, FRCS, a retired US Navy Commander from Philadelphia, who is among the growing number of trauma surgeons urging national trauma readiness. During the Edward D. Churchill Lecture at the American College of Surgeons (ACS) Clinical Congress in Chicago, Dr. Schwab said that the US healthcare system's ability to respond to mass casualty events, including warfare-related injuries, is predicated on the preparedness of every surgeon and hospital system. Talk about the podcast on social media using the hashtag #HouseofSurgery.
Desmond Bane had a big night in the NBA Cup game against Miami which leads us to a conversation on which former Grizzlies players we actively root for or against (5:37) + Charles Huff will be introduced as the new Memphis Head Football Coach today and why we think he will win the press conference (29:38) + Philip Rivers had his press conference in Indianapolis and answered why he decided to come back to the NFL (44:20) + there's an 8th grader at FACS who has been playing varsity since he was in the 6th grade. His name is Eric Blount Jr and we'll show his highlights (51:23) + Jessica Benson joins the show in-studio to give us her 5 favorite Bowl Games (1:08:35) Host: Chris Vernon Co-Hosts/Contributors: Jon Roser, Devin Walker Guest: Jessica BensonTechnical Director: Jaylon Wallace Associate Producer: Jena Broyles
Dr. Adam Dorsay, psychologist and host of the SuperPsyched podcast, interviews Dr. Sharon Chang, a distinguished surgical oncologist educated at Harvard Medical School. Dr. Chang shares her journey in the demanding field of surgical oncology, including the rigorous schedules, challenges of being a female in a traditionally male-dominated field, and work-life balance. She discusses her routines for maintaining physical and mental health, the creation of psychological safety within surgical teams, and the importance of caring deeply for patients. Dr. Chang also shares her transition into coaching, focusing on mental fitness for healthcare professionals, and her efforts to combat burnout and advocate for lifestyle medicine. The episode provides a compelling and insightful look into the high-stakes world of a cancer surgeon and the valuable lessons learned along the way.00:00 Introduction to SuperPsyched00:35 Meet Dr. Sharon Chang: A Life-Saving Surgeon03:00 Challenges and Triumphs of a Female Surgeon04:50 Balancing Surgery and Motherhood06:43 Self-Care and Physical Fitness08:29 A Day in the Life of a Surgeon15:30 Handling Surgical Surprises20:56 The Importance of Teamwork and Psychological Safety26:29 Exploring Plastic Surgery and Patient Experiences27:33 Communicating with Patients and Families28:01 The Impact of Social Media on Medical Information29:59 Humor in Medicine: Dr. Glaucomflecken and Misinformation https://youtube.com/@dglaucomflecken?si=6K46jj4z2LeMBfMZ32:35 Delivering Good and Bad News to Patients36:29 The Importance of Caring in Medicine43:13 Transitioning to a Career in Coaching47:30 Sharon Chang's Triple Aim for Healthcare51:35 Final Thoughts and ReflectionsHelpful Links:Sharon B. Chang, MD, FACS LinkedIn
In this episode, Gregory J. Tiesi, MD, FACS, FSSO, hosted a discussion about the use of hepatic artery infusion (HAI) in colon cancer and liver cancer management. Dr Tiesi is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Jersey Shore University Medical Center in Toms River and Brick, New Jersey. He was joined by: Anthony Scholer, MD, FACS, FSSO, a surgical oncologist specializing in hepatobiliary surgery, at Hackensack Meridian Medical Group and Jersey Shore University Medical Center in Neptune, New Jersey Benjamin Jon Golas, MD, FACS, regional chief of Surgical Oncology for Hackensack Meridian Health's Central Region, surgical director of Oncology Services at Jersey Shore University Medical Center, vice chair of Surgery at Jersey Shore University Medical Center Cancer Surgery, and an associate professor of surgery at the Hackensack Meridian School of Medicine in Neptune and Edison, New Jersey Eric Pletcher, MD, a surgeon specializing in Complex General Surgical Oncology at Hackensack Meridian JFK University Medical Center in Edison Drs Tiesi, Scholer, Golas, and Pletcher explained that HAI is a longstanding regional therapy used for treating primary and metastatic tumors to the liver, notably unresectable colorectal liver metastases and intrahepatic cholangiocarcinoma. The physiologic mechanism of this treatment leverages the dual blood supply of the liver, capitalizing on the fact that these malignancies primarily derive their perfusion from the hepatic artery, the experts noted. They emphasized that by delivering chemotherapeutic agents, such as floxuridine, directly via the gastroduodenal artery, HAI concentrates drug exposure at the tumor site, maximizing antitumor effect and minimizing extrahepatic toxicity. They explained that patient selection requires fitness for surgery and good liver function, excluding those with cirrhosis or portal hypertension. They also noted that the procedure involves implanting a subcutaneous pump, followed by rigorous intraoperative and postoperative nuclear medicine studies to confirm the absence of extrahepatic perfusion. Evidence supports that HAI combined with systemic therapy achieves higher intrahepatic objective responses, improves local disease control, and enhances conversion to resectability, correlating with improved long-term survival, the experts reported. However, potential complications include pump pocket infections, biliary sclerosis, and gastric ulcers, they added. The experts concluded by highlighting that establishing an HAI program necessitates a robust, multidisciplinary approach involving surgical oncology, medical oncology, and interventional radiology.
PODCAST: On this episode of the WGNS Action Line, host Scott Walker sits down with Dr. Craig McCabe, MD, PhD, FACS of McCabe Vision Center on Heritage Park Drive in Murfreesbo
This episode features William E. Cohn, MD, FACS, a cardiothoracic surgeon from Houston, Texas, who delivered the I. S. Ravdin Lecture during the American College of Surgeons (ACS) Clinical Congress in Chicago. In his lecture, “The Past, Present, and Future of the Total Artificial Heart,” Dr. Cohn not only explored the history of artificial heart innovation but also the paradigm-shifting work that may finally bring a permanent solution for end- stage heart failure. Talk about the podcast on social media using the hashtag #HouseofSurgery
In this episode, Gregory J. Tiesi, MD, FACS, FSSO, hosted a discussion about innovations in regional cancer therapies. Dr Tiesi is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Jersey Shore University Medical Center in Toms River and Brick, New Jersey. He was joined by: Anthony Scholer, MD, FACS, FSSO, a surgical oncologist specializing in hepatobiliary surgery, at Hackensack Meridian Medical Group and Jersey Shore University Medical Center in Neptune, New Jersey Benjamin Jon Golas, MD, FACS, regional chief of Surgical Oncology for Hackensack Meridian Health's Central Region, surgical director of Oncology Services at Jersey Shore University Medical Center, vice chair of Surgery at Jersey Shore University Medical Center Cancer Surgery, and an associate professor of surgery at the Hackensack Meridian School of Medicine in Neptune and Edison, New Jersey Eric Pletcher, MD, a surgeon specializing in Complex General Surgical Oncology at Hackensack Meridian JFK University Medical Center in Edison Drs Tiesi, Scholer, Golas, and Pletcher chatted about the use of pressurized intraperitoneal aerosolized chemotherapy (PIPAC), a minimally invasive regional cancer therapy designed for patients with peritoneal metastases or primary peritoneal cancers. The experts explained that this laparoscopic approach overcomes several limitations of traditional systemic treatments by delivering aerosolized chemotherapy in fine droplets under high pressure into the peritoneal cavity. This process ensures uniform drug distribution and enhanced tissue penetration, allowing for efficacy with lower systemic drug concentrations, they noted. PIPAC candidates typically present with unresectable or recurrent disease, or symptomatic malignant ascites, and should have an ECOG performance status between 0 and 2, they elaborated. The procedure, which is repeatable every 4 to 6 weeks, includes diagnostic laparoscopy, quantification of the peritoneal carcinomatosis index, and serial biopsies to assess treatment response. They emphasized that PIPAC has a favorable safety profile, with low 30-day mortality rates and minimal grade 3/4 adverse effects reported in clinical trials. Additionally, they stated that clinical data indicate high pathologic response rates and the potential for disease downstaging, enabling some patients who were initially deemed unresectable to become eligible for subsequent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Of note, the experts reported that PIPAC is designed to be integrated seamlessly with concurrent systemic therapy.
In the first installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guests Julia A. Haller, MD, CEO, and David F. Chang, MD. Welcome to the Eyeluminaries podcast 00:10 Quick recap of episode 34 00:52 Intro of Julia A. Haller, MD, CEO 01:47 Tell us about changes you're seeing in leading a large academic center 02:16 How has residency changed in the last years? 06:23 Why are you involved in the Ophthalmology Foundation? 13:05 Intro of David F. Chang, MD 16:51 What do you think about the future of robotics in cataract surgery? 17:51 How do you continue to involve the patient in their care? 20:15 Dr. Chang discusses premium lenses 22:43 What's going on with EyeSustain and what are you excited about in the future? 27:00 Thank you! 35:30 Julia A. Haller, MD, is ophthalmologist-in-chief and CEO at Wills Eye Hospital. David F. Chang, MD, is a world-renowned cataract surgeon and innovator in the field. He is clinical professor of ophthalmology at the University of California, San Francisco, and is in private practice in Los Altos, Calif. He is also the chair of the EyeSustain advisory board. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.
Epi 5Think you're ready for plastic surgery? Think again.In this eye-opening episode of the Cutting Edge Podcast, Mel sits down with Ashlyn Douglass-Barnes and Dr. Omar E. Beidas (MD, FACS) to reveal the raw truth about post-op recovery — the stuff you won't hear during a consult.Whether you're prepping for lipo 360, skin removal, or bariatric plastic surgery, this is the real talk you need.
How far are people willing to go for glass skin and a clear face? For years, we have witnessed adventurous — and sometimes extreme — pursuits within skincare and cosmetic treatments in the quest for ageless beauty. We've heard it all: the Vampire Facial, human placenta for collagen, snail slime, and, in recent years, salmon sperm DNA. From celebrities like Jennifer Aniston to Kim Kardashian, salmon sperm facials have become the latest craze promising skin regeneration, brightening, and that coveted youthful glow. But what exactly is salmon sperm DNA therapy, and does it actually work — or is it just another viral beauty trend swimming through social media?In this episode, we are joined by Dr. Lanna Cheuck, DO, FACS. Dr. Cheuck is a board-certified urologic surgeon specializing in aesthetics and sexual health and is the CEO and Medical Director of LC Medical Aesthetics, a medical spa empire with multiple locations specializing in cosmetic surgery, injectables, sexual health.Dr. Cheuck received her DO from the NYIT College of Osteopathic Medicine, completed her Urology Residency at Brown University, and pursued a Minimally Invasive Urologic Surgery Fellowship at Albert Einstein College of Medicine. Currently, Dr. Cheuck is an Assistant Professor of Head and Neck Facial Anatomy at Montefiore Hospital, National Trainer for Galderma Aesthetics (a center of education for GAIN training), Owner and National Trainer for FACE Med-Spa Training, Co-Founder of FACE Med Store, and the Host and Co-Founder of Future of Aesthetics Global Summit (an inclusive network for virtual aesthetics). Dr. Cheuck has been featured on Forbes, Cosmopolitan, New York Post, Well+Good, RealSelf News, Global Woman Magazine, Asian Hustle Network, and NewBeauty.Follow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz (Host): Instagram, YouTube
This episode provides a new perspective on how modern surgical practice has been shaped by military surgical history and how history can provide surgeons with a deepened appreciation for the events that have transformed patient care. Colonel (Ret.) Jeremy W. Cannon, MD, SM, FACS, leads the discussion that includes a medical student, junior faculty member, and senior surgeon/historian. Dr. Cannon's guests are Gordon L. Telford, MD, FACS, Justin Barr, MD, PhD, and Karina Hiroshige. HOST Colonel (Ret.) Jeremy W. Cannon, MD, SM, FACS, USAF Reserve, MC, trauma surgeon at Penn Medicine in Philadelphia and Past President of the Excelsior Surgical Society GUESTS Gordon L. Telford, MD, FACS, retired general surgeon from the Medical College of Wisconsin, in Milwaukee Justin Barr, MD, PhD, transplant and hepatobiliary surgeon at the Ochsner Clinic in New Orleans, LA Karina Hiroshige, MD/MBA Candidate at the University of Rochester School of Medicine & Dentistry, NY, and Research Fellow in Trauma, Surgical Critical Care & Emergency Surgery at the University of Pennsylvania, Philadelphia Talk about the podcast on social media using the hashtag #HouseofSurgery
Dr. Hoffman continues his conversation with Alan Frost, founder of Flava Naturals, and Dr. Joseph C. Maroon, MD, FACS, clinical professor and vice chairman of the Department of Neurological Surgery and Heindl Scholar in Neuroscience at the University of Pittsburgh Medical Center, and author of "The Science of Cocoa."
Alan Frost, founder of Flava Naturals, and Dr. Joseph C. Maroon, MD, FACS, clinical professor and vice chairman of the Department of Neurological Surgery and Heindl Scholar in Neuroscience at the University of Pittsburgh Medical Center, and author of "The Science of Cocoa," detail recent scientific findings on the cardiovascular and cognitive benefits of cocoa flavanols, the importance of sourcing and processing cocoa, and how cocoa can enhance athletic performance and brain health. The episode also covers the benefits of cocoa for skin health, fighting inflammation, and even mitigating some of the effects of sitting. Dr. Maroon elaborates on his protocols for concussion recovery, including the use of omega-3 fish oil, creatine, and CBD. The episode concludes with a discussion on how cocoa impacts mood and a special discount offer for Flava Naturals products. Just go to FlavaNaturals.com and use coupon code HOFFMAN20 for 20% off site-wide, plus get free shipping on all orders over $30.
#ThisMorning | #Ultra-#Processed #Foods Can #Drive Your #Colorectal #Cancer #Risk | Tim Yeatman, MD, FACS & Ganesh Halade, PhD., USF Health Heart Institute | #Tunein: broadcastretirementnetwork.com #Aging, #Finance, #Lifestyle, #Privacy, #Retirement, #Wellness
David I. Sandberg, M.D., FACS, FAAP, is a fellowship-trained pediatric neurosurgeon who is the director of pediatric neurosurgery at McGovern Medical School at The University of Texas Health Science Center at Houston He has a special clinical and research interest in pediatric brain tumors, and specializes in minimally invasive endoscopic approaches to brain tumors, hydrocephalus and arachnoid cysts, as well as surgical management of arteriovenous malformations of the brain, congenital spinal anomalies, spasticity and craniofacial anomalies. The recipient of numerous research grants, he has pioneered novel treatment approaches for pediatric brain tumors, and he is principal investigator of several clinical trials. Get his brilliant new book Brain and Heart: The Triumphs and Struggles of a Pediatric Neurosurgeon Anthony Scaramucci is the founder and managing partner of SkyBridge, a global alternative investment firm, and founder and chairman of SALT, a global thought leadership forum and venture studio. He is the host of the podcast Open Book with Anthony Scaramucci. A graduate of Tufts University and Harvard Law School, he lives in Manhasset, Long Island.
In this episode, Tom Varghese, MD, FACS, is joined by Ziad Sifri, MD, FACS, from Rutgers New Jersey Medical School, and Matthew Linz, MD, from Rutgers Robert Wood Johnson Medical School. They discuss Drs Sifri and Linz's recent article, “Postoperative Pain Management in the US vs Low- and Middle-Income Countries by US Surgeons,” in which they found that surgeons in the US prescribe significantly more opioids after inguinal hernia repair compared with when they operate on short-term surgical trips to low- and middle-income countries, despite continued efforts to reduce opioid overprescription in the US. Disclosure Information: Drs Varghese, Linz, and Sifri have nothing to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Linz, Matthew S MD1; Parvin-Nejad, Fatemeh P MD2; Srinivasan, Nivetha MD3; Vegunta, Geetasravya MD1; Eng, Ashley K BS1; Kim, Eugene BA MBS; Alexander, Imani BS1; Elgammal, Fatima MD2; Benson, Ryan MD2; Benneh, Albert Y MD4; Gyakobo, Mawuli K MD5,6; Lopez, Lorena MD7; Jalloh, Samba MD8; Sifri, Ziad C MD FACS2. Postoperative Pain Management in the US vs Low-and-Middle-Income Countries by US Surgeons. Journal of the American College of Surgeons ():10.1097/XCS.0000000000001538, July 30, 2025. | DOI: 10.1097/XCS.0000000000001538 Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA credit will be available until October 29, 2026.To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA credit will be available until October 29, 2026.To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA credit will be available until October 29, 2026.To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA credit will be available until October 29, 2026.To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA credit will be available until October 29, 2026.To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA credit will be available until October 29, 2026.To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In the final part of this 3-part series, Dr Terris discussed how the early diagnosis of bladder cancer presents a significant challenge, particularly in female patients, who are frequently diagnosed at a later stage of the disease and subsequently respond less favorably to treatment modalities. A crucial component of early detection is the rigorous evaluation of hematuria, she emphasized. Microhematuria is defined strictly by microscopy. Reliance solely on a dipstick test is insufficient; any positive dipstick result necessitates a microscopic examination, she explained. Furthermore, patients currently receiving anticoagulation therapy do not bypass the standard workup, she noted. If hematuria is identified alongside a urinary tract infection or gynecological issue, the urine should be rechecked once the co-existing problem has cleared, she advised. Risk assessment must consider both common and less-recognized factors, particularly in women, according to Terris. Standard risks include exposure to cyclophosphamide or ifosfamide, Lynch syndrome, chronic indwelling Foley catheters, benzene/aromatic amine exposure, and smoking, she added. However, uro-oncologists must actively assess female patients for occupational exposures not traditionally associated with bladder cancer, she said. Patients presenting with microhematuria should be stratified into low-, intermediate-, or high-risk groups, Terris continued. The gold standard evaluation for high-risk patients is a cystoscopy and CT urogram, she reported. The CT urogram involves cross-sectional imaging of the abdomen and pelvis with and without contrast, incorporating delayed images to optimally visualize the renal pelvis and ureters for potential filling defects, she noted. If patients cannot tolerate contrast, an MR urogram is the primary alternative, she stated. If neither CT nor MR urogram can be performed, the default workup is non-contrast CT combined with cystoscopy and retrograde pyelograms, although this requires general anesthesia, she explained. Given that women are often diagnosed with bladder cancer late and face poor outcomes with advanced disease, maintaining a heightened awareness and low threshold for investigation is critical, Terris concluded.
Aujourd'hui, Didier Giraud, éleveur de bovins, Bruno Poncet, cheminot, et Barbara Lefebvre, prof d'histoire-géo, débattent de l'actualité autour d'Alain Marschall et Olivier Truchot.
Uday Devgan, MD, FACS, FRCS, speaks with Christopher E. Starr, MD, FACS, and Brian Shafer, MD, in two short segments drawn from CRST's October cover focus, "Refractive Cataract Roundtables." Dr. Starr reviews a practical approach to preoperative ocular surface optimization—key exam steps, stop-rules before biometry, and simple readiness markers. Dr. Shafer outlines his IOL decision framework, balancing spectacle independence and image quality, who is not a candidate for diffractive optics, and options for residual refractive error. Related perspectives appear in the October issue of CRST.
Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In part 2 of this 3-part series, Dr Terris discussed the disparities in treatment and outcomes for women with bladder cancer. Although bladder cancer is less common in females than in males, female patients tend to have significantly worse outcomes, Terris explained. Delayed diagnosis is a contributing factor, but the exact reasons for the poorer prognosis are not fully understood, she emphasized. Treatment difficulties begin surgically, according to Terris. From a surgical perspective, she noted that, performing a cystectomy on a woman is more challenging due to factors like pelvic varicosities and differing fat distribution, which complicate stoma creation. In terms of medical treatment, Terris also explained that women exhibit worse tolerability and higher rates of discontinuation of immunotherapy, and that they often experience poor efficacy outcomes regardless of whether they complete the course of treatment. These differences between men and women may be linked to factors such as hormonal influences or antibody introduction during pregnancy. Conversely, classic cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy have been shown to have similar overall survival and disease-free survival in eligible female and male patients. Biologically, Terris also reported that tumors in women may exhibit more effective immune escape mechanisms, possibly connected to differences in the bladder microbiome. The presence of bacteria in bladder tumors has been found to be enriched in patients who did not respond to neoadjuvant chemotherapy, which is relevant as women are more prone to bladder colonization, she added. Overall, Terris emphasized that oncologists must be aggressive in treating women with bladder cancer, despite surgical complexities, and highlighted that early detection is key.
Episode 767: November 8, 2025 playlist: Marie Davidson, "Push Me Fuckhead (Soulwax Dub Mix)" (City Of Clowns (MDJ Tools)) 2025 Deewee Paula Kelley, "Party Line" (Blinking as the Starlight Burns Out) 2026 Wharf Cat Tashi Dorji, "gathering" (low clouds hang, this land is on fire) 2026 Drag City FACS, "Teenage Hive (Physical Medium Remix)" (Teenage Hive (Physical Medium Remix)) 2025 [self-released] K-LONE, "slk" (sorry i thought you were someone else) 2025 Incienso A Place to Bury Strangers, "On The Wire" (Music For Gaza Soup Kitchen) 2025 Funds for Gaza Gnonnas Pedro and His Dadjes Band, "Adigbedoto" (Roi De L'Agbadja Moderne 1974-1983) 2025 Analog Africa Ginger Beef, "Takeout" (Ginger Beef) 2025 Ba Da Bing! Ruth Mascelli and Mary Hanson Scott, "A Lover's Theory Of Value" (Esoteric Lounge Music Now) 2025 Disciples Brown Angel, "Dame Mas" (Pure Brown Energy) 2025 Dark Entries Le Grand Couturier, "Adventures In Paradise" (Le Grand Couturier) 2025 unjenesaisquoi Call Super, "Mothertime" (A Rhythm Protects One) 2025 Dekmantel The Stargazer Lilies, "Eleven O Eight" (Eleven O Eight) 2025 [self-released] Pete Namlook and Ludwig Rehberg, "Amourette" (The Putney) 1993 Fax Email podcast at brainwashed dot com to say who you are; what you like; what you want to hear; share pictures for the podcast of where you're from, your computer or MP3 player with or without the Brainwashed Podcast Playing; and win free music! We have no tracking information, no idea who's listening to these things so the more feedback that comes in, the more frequent podcasts will come. You will not be put on any spam list and your information will remain completely private and not farmed out to a third party. Thanks for your attention and thanks for listening.
The importance of the four R's to keep top of mind as you navigate your leadership journey is presented by Joseph E. Losee, MD, MBA, FACS, FAAP, a beloved return guest, on the Faculty Factory Podcast this week. Dr. Losee is Vice Dean for Faculty Affairs at the University of Pittsburgh School of Medicine, the Dr. Ross H. Musgrave Endowed Chair in Pediatric Plastic Surgery, a Professor and Executive Vice Chair of the Department of Plastic Surgery, and a Professor of Business Administration at Katz Graduate School of Business. You can revisit his other episodes with us here: Embracing Resilience in Academic Medicine: https://facultyfactory.org/joseph-losee/ Examining the Need for Scientist Wellbeing Initiatives: https://facultyfactory.org/scientist-burnout/ You can also see slides from his “Four R's of Leadership” presentation here. [pdf] As discussed, leaders are often hired for their IQ but get fired for a lack of emotional intelligence (EQ). The good news? EQ can be learned, exercised, and grown. The four R's or leadership are as follows: Responsibility Regulation Resilience Relationships Recommended readings from this episode include Executive Presence 2.0 by Sylvia Ann Hewlett. How you act, speak, and appear—all matter as a leader, according to this literature, which Dr. Losee mentioned in the opening moments of the podcast. He also referenced the TEDx Talk "Let's Face It: Charisma Matters" by John Antonakis, which you can view here: https://www.youtube.com/watch?v=SEDvD1IICfE “Charisma matters and it can be taught and learned,” as Dr. Losee told us. Other books and resources mentioned include: Teaming: How Organizations Learn, Innovate, and Compete in the Knowledge Economy by Amy C. Edmondson The Fearless Organization: Creating Psychological Safety in the Workplace for Learning, Innovation, and Growth by Amy C. Edmondson TED Talk: Lucy Hone — The Three Secrets of Resilient People Building a Resilience Bank Account article by Michael A. Maddaus, MD: https://www.annalsthoracicsurgery.org/article/S0003-4975(19)31352-9/fulltext Burnout and Satisfaction With Work-Life Balance Among U.S. Physicians Relative to the General U.S. Population: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1351351
This episode features a fireside chat with Gerald B. Healy, MD, FACS, an otolaryngologist—head and neck surgeon, with a long career of service to the ACS, including as President of the Massachusetts Chapter, Chair of the Board of Regents, and ACS president. The program host is Mohsen M. Shabahang, MD, PhD, FACS, for the ACS Academy of Master Surgeon Educators. Talk about the podcast on social media using the hashtag #HouseofSurgery.
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction Presenters: George E. Koch, MD & Kurt A. McCammon, MD, FACS
Epi 1Welcome to the first episode of our NEW series on The Sleeved Life Podcast!If you've had bariatric surgery, are considering plastic surgery after weight loss, or struggling with mental health during your transformation — this is for you.
On this episode of Cancer Registry World, we welcome Dr. Charles M. Balch, MD, FACS—an internationally recognized surgical oncologist and melanoma expert. Dr. Balch shares his insights on how cancer registry data plays a pivotal role in advancing clinical trials and evaluating patient outcomes, particularly in melanoma care. Join us for a compelling conversation that highlights the power of registries in shaping evidence-based oncology.
Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In part 1 of this 3-part series, Dr Terris discussed the prevalence of bladder cancer in women, as well as reasons for diagnostic disparities that contribute to poor treatment outcomes. She noted that this disease is often diagnosed at later stages in women than in men, often resulting in diagnoses of more advanced disease and translating to poorer outcomes. She added that although female patients represent a minority of those with urothelial carcinoma, retrospective data indicate that women tend to be diagnosed at later stages and consequently experience worse survival rates, regardless of the disease stage. Dr Terris identified several theories explaining why this diagnosis delay occurs. One possible reason is patient-related: women may be less likely than men to consult a physician when they notice blood in their urine because they may be conditioned to dismiss blood if they experience menstrual bleeding. However, physician behavior and bias also contribute to diagnostic disparities, Terris said. Women with suspected hematuria typically receive fewer imaging tests, she continued. Additionally, physicians may be biased, attributing hematuria to uterine bleeding, menstruation, or other benign causes. Overall, Terris emphasized that early detection is key. If there is any suspicion of a malignancy, patients should be referred directly to a urologist, she stated. Urologists should be willing to work up cases that might ultimately be recurrent urinary tract infections or radiation cystitis to avoid undiagnosed cases of bladder cancer in women, she concluded.
Today I sit down with Dr. Reza Movahed, an oral and maxillofacial surgeon who's making a real impact in the scleroderma community. As scleroderma patients we know how this disease affects the mouth. Dr. Movahed helps patients regain function and comfort, and the surprising role sleep plays in maintaining oral health. Dr. Movahed was a crowd favorite at our July conference.
In today's episode, we had the pleasure of speaking with Neal Shore, MD, FACS, about the use of androgen deprivation therapy (ADT) in prostate cancer management. Dr Shore is medical director of the Carolina Urologic Research Center in Myrtle Beach, South Carolina. In our exclusive interview, Dr Shore discussed guidelines for incorporating ADT into prostate cancer clinical practice, toxicities and quality-of-life complications associated with this class of agents that health care providers should be aware of and try to mitigate, and the importance of shared decision-making between members of the multidisciplinary team, as well as patients.
Dr. Robert Beltran isn't just a doctor—he's a man who healed himself to heal others.A highly respected triple board-certified surgeon and pharmacist ($MD, PharmD, FACS$), Dr. Beltran had a decades-long career as an ENT and cosmetic surgeon, giving him a rare, deep understanding of the human body, from biochemistry to the operating room.His life and career changed in 2014 when a severe accident left him battling chronic pain, cognitive fog, and depression. What traditional medicine couldn't fix, a colleague's suggestion of herbal treatments miraculously did—sparking a rapid turnaround that helped him safely overcome his dependency on prescription pain medication, including oxycodone.This life-altering personal recovery ignited a new mission. Dr. Beltran dedicated the next decade to merging his clinical and scientific background with the power of nature. Today, as CEO and Chief Formulator of recomnd Nutrition, he applies his surgical precision and pharmacy knowledge to create science-backed, plant-based solutions for physical and cognitive vitality.Join us to hear this inspiring story of resilience and reinvention. Dr. Beltran will share how he challenges conventional thinking on recovery, helping people reclaim their well-being without relying on harsh side effects or stimulants. HELP SUPPORT OUR FIGHT AGAINST ADDICTION. DONATE HERE: https://www.patreon.com/theaddictionpodcast PART OF THE GOOD NEWS PODCAST NETWORK. AUDIO VERSIONS OF ALL OUR EPISODES: https://theaddictionpodcast.com CONTACT US: The Addiction Podcast - Point of No Return theaddictionpodcast@yahoo.com Intro and Outro music by: Decisions by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100756 Artist: http://incompetech.com/
In this episode, Lillian Erdahl, MD, FACS, is joined by Eilidh Gunn, MBChB MRCSEd, from the Surgical Sabermetrics Laboratory at the University of Edinburgh. They discuss Dr Gunn's recent article, “What About the Coach? Mixed-Methods Study Assessing the Experience of Coaches in a Peer Surgical Coaching Program.” As peer-led surgical coaching becomes an increasingly popular professional development activity, this study explores the impact of participation on surgeons acting as coaches. Using a concurrent, mixed-methods design, results demonstrate that coaches found participation worthwhile and that it affected their own clinical practice. Learn more about the SCOPE program here. Disclosure Information: Drs Gunn and Erdahl have nothing to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord
This episode features Vinay Badhwar, MD, FACS, FACC, Executive Chair of the WVU Heart & Vascular Institute and Gordon F. Murray Professor and Chair of the Department of Cardiovascular & Thoracic Surgery at West Virginia University School of Medicine. Dr. Badhwar discusses the importance of a strong organizational structure, shares insights into the innovative developments his team has been working on, reflects on the values that guide him as a leader, and much more.
This episode features Anton N. Sidawy, MD, MPH, FACS, who was installed during Clinical Congress 2025 in Chicago as the American College of Surgeons (ACS) 106th President. Shortly afterward, he delivered his Presidential Address, urging unity across all surgical disciplines and calling the ACS “The House of Surgery: A Home for All Surgeons.” Talk about the podcast on social media using the hashtag #HouseofSurgery.
On this episode, B. Marie Ward, MD, MPH, FACS, Director of Breast Surgery in the Department of Surgery at NYC Health + Hospitals/Jacobi, joins the podcast to discuss breakthroughs in breast cancer research and awareness, including decreasing mortality rates and improving treatment options. She also highlights the importance of health equity and emphasizes why regular mammograms are vital for early detection and better outcomes.
In the second episode of the four-part Quality Improvement (QI) Project Guide series, Martin A. Koyle MD, MSc, MMgmt, MBA(cert.), FAAP, FACS, FRCSC, FRCS (Eng.), FRSM, and Kara Watts, MD, join Andrew Harris, MD, MBA, Chair of AUA's Quality Improvement and Patient Safety (QIPS) Committee, for a conversation on AUA's new QI Project Guide. They discussed the planning phase of a QI project and how strong preparation can set a project up for success.
According to the Centers for Disease Control, about 10% to 20% of lung cancers diagnosed in the United State, or 20,000 to 40,000 lung cancers each year, happen in people who never smoked or smoked fewer than 100 cigarettes in their lifetime. Join us as Dr. Alden Maier discusses how this is possible and what nonsmokers should know when it comes to knowing the symptoms and risks for lung cancer. Learn more about Alden Maier, MD, FACS
On this episode, B. Marie Ward, MD, MPH, FACS, Director of Breast Surgery in the Department of Surgery at NYC Health + Hospitals/Jacobi, joins the podcast to discuss breakthroughs in breast cancer research and awareness, including decreasing mortality rates and improving treatment options. She also highlights the importance of health equity and emphasizes why regular mammograms are vital for early detection and better outcomes.
This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This first episode highlights the colon cancer operative standard. Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology fellow at MD Anderson Cancer Center. Guest: George Chang, MD, MS, MHCM, FACS, FASCRS, FSSO is a Professor and the interim Department Chair in the Department of Colon and Rectal Surgery at MD Anderson Cancer Center. Learning Objectives: The extent of colon mobilization and resection depends on tumor location, with high vascular ligation of the tumor-bearing segment to complete adequate regional lymphadenectomy. The technical steps of right colectomy are reviewed, including high ligation of the ileocolic pedicle at the level of the superior mesenteric vein, and the right branch of the middle colic artery if present. Tips and tricks are discussed to identify vascular structures and avoid central vascular injury. Links to Papers Referenced in this Episode Operative Standards for Cancer Surgery, Volume 1: Breast, Lung, Pancreas, Colon https://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/ Kindle edition: https://www.amazon.com/Operative-Standards-Cancer-Surgery-Section-ebook/dp/B07MWSNFSB Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomized, controlled, phase 3, superiority trial Lancet Oncol. 2021 Mar; 22(3):391-401. https://pubmed.ncbi.nlm.nih.gov/33587893/ Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer. Ann Surg Oncol. 2018 Jan;25(1):38-45. https://pubmed.ncbi.nlm.nih.gov/27942902/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
In this kickoff episode of the Behind the Knife Global Surgery Series, we dive into what global surgery really means—and why it matters to all of us. Five billion people lack access to safe, timely, and affordable surgical care. Our guest, Dr. Juan Carlos Puyana, shares powerful insights on redefining global surgery, building meaningful collaborations, and why surgeons in high-resource countries should care deeply about this work. If you want to broaden your vision of surgery, challenge assumptions, and hear stories that connect operating rooms from South Carolina to South Africa, this is an episode you won't want to miss. Hosts/Guest: Mike M. Mallah, MD, FACS, FICS Director of Global Surgery at Medical University of South Carolina @MikeMMallahMD @MUSCGlobalSurg mallahm@musc.edu Juan Carlos Puyana, MD, FACS O'Brian Chair of Global Surgery at the Royal College of Surgeons Ireland @jcpuyanamd @RCSI_GlobalSurg Learning objectives: Define global surgery and explain how its meaning has evolved to highlight disparities in access to safe, timely, and affordable surgical care worldwide. Recognize the value of global surgery engagement for trainees and surgeons in high-resource settings, including broadening perspectives and fostering humility. Identify principles of ethical collaboration in global surgery, using real-world examples of partnerships built on trust, mutual respect, and shared goals. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
Surgical resection of perihilar cholangiocarcinoma (pCCA) is one of the highest-risk elective operations performed. The obstructive jaundice suffered by patients preoperatively, central location of the tumors, and extensive nature of the resection make pCCA one of the most challenging HPB disease processes. In this episode from the HPB team at Behind the Knife, listen in on the discussion about perioperative strategies to improve outcomes for surgical resection of perihilar cholangiocarcinoma. Hosts Anish J. Jain MD (@anishjayjain) is a current PGY4 General Surgery Resident at Stanford University and a former T32 Research Fellow at the University of Texas MD Anderson Cancer Center. Timothy E. Newhook MD, FACS (@timnewhook19) is an Assistant Professor within the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center. He is also the associate program director of the HPB fellowship. Jean-Nicolas Vauthey MD, FACS (@VautheyMD) is Professor of Surgery and Chief of the HPB Section, as well as the Dallas/Fort Worth Living Legend Chair of Cancer Research in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center. Learning Objectives · Develop an understanding of the three treatment sequences for resection of disease in patients with synchronous liver metastasis from a primary rectal cancer (reverse, combined, and classic approach) · Develop an understanding of the benefits, risks, and nuances of each of the three treatment sequences · Develop an understanding of which patient cases each treatment sequence is ideal for as well as which cases they are not suitable for. Papers Referenced: 1) Ribero D, Zimmitti G, Aloia TA, Shindoh J, Fabio F, Amisano M, Passot G, Ferrero A, Vauthey JN. Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma. J Am Coll Surg. 2016 Jul;223(1):87-97. https://pubmed.ncbi.nlm.nih.gov/27049784/ 2) Jain AJ, Lendoire M, Haddad A, Tzeng CD, Boyev A, Maki H, Chun YS, Arvide EM, Lee S, Hu I, Pant S, Javle M, Tran Cao HS, Vauthey JN, Newhook TE. Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience. Ann Surg Oncol. 2025 Jun;32(6):4352-4362. https://pubmed.ncbi.nlm.nih.gov/40000564/ Additional Suggested Reading Olthof PB, Erdmann JI, Alikhanov R, Charco R, Guglielmi A, Hagendoorn J, Hakeem A, Hoogwater FJH, Jarnagin WR, Kazemier G, Lang H, Maithel SK, Malago M, Malik HZ, Nadalin S, Neumann U, Olde Damink SWM, Pratschke J, Ratti F, Ravaioli M, Roberts KJ, Schadde E, Schnitzbauer AA, Sparrelid E, Topal B, Troisi RI, Groot Koerkamp B; Perihilar Cholangiocarcinoma Collaboration Group. Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible. Ann Surg Oncol. 2024 Jul;31(7):4405-4412. https://pubmed.ncbi.nlm.nih.gov/38472674/ Mueller M, Breuer E, Mizuno T, Bartsch F, et al. Perihilar Cholangiocarcinoma - Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers. Ann Surg. 2021 Nov 1;274(5):780-788. https://pubmed.ncbi.nlm.nih.gov/34334638/ Ad Disclosures: Visit goremedical.com/btk to learn more about GORE® ENFORM Biomaterial. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
Join the Behind the Knife Surgical Oncology Team as we discuss the nuances in the work up and management of patients with pheochromocytomas. Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center. Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles. Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 2ndYear Surgical Oncology fellow at MD Anderson. Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a General Surgery physician in the United States Air Force station at RAF Lakenheath. Joe (Joseph) Broderick, MD, MA (@joebrod5) is a General Surgery research resident between his second and third year at Brooke Army Medical Center. Galen Gist, MD (@gistgalen) is a General Surgery research resident between his second and third year at Brooke Army Medical Center. Learning Objectives: 1) Review the presentation of patients with pheochromocytomas. 2) Review the work up of patients with pheochromocytomas. 3) Review the treatment of patients with pheochromocytomas. 4) Review the surveillance of patients with pheochromocytomas. References used in the making of this episode: Patel D. Surgical approach to patients with pheochromocytoma. Gland Surg. 2020;9(1):32-42. doi:10.21037/gs.2019.10.20. PMID: 32206597; PMCID:PMC7082266. Eisenhofer G, Lenders JW, Siegert G, et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012;48(11):1739-1749. doi:10.1016/j.ejca.2011.07.016. PMID:22036874; PMCID: PMC3372624. Lenders JWM, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665-675. doi:10.1016/S0140-6736(05)67139-5. Vicha A, Musil Z, Pacak K. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options. Curr Opin Endocrinol Diabetes Obes. 2013;20(3):186-191. doi:10.1097/MED.0b013e32835fcc45. PMID: 23481210; PMCID: PMC4711348. https://pubmed.ncbi.nlm.nih.gov/23481210/ Dickson PV, Alex GC, Grubbs EG, et al. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2011;150(3):452-458. doi:10.1016/j.surg.2011.07.004. https://pubmed.ncbi.nlm.nih.gov/21878230/ Lei K, Wang X, Yang Z, et al. Comparison of the retroperitoneal laparoscopic adrenalectomy versus transperitoneal laparoscopic adrenalectomy for large (≥6 cm) pheochromocytomas: a single-centre retrospective study. Front Oncol. 2023;13:1043753. doi:10.3389/fonc.2023.1043753. PMID: 36910608; PMCID: PMC9992891. https://pubmed.ncbi.nlm.nih.gov/36910608/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
Can AI transcend its role from a mere tool to a pivotal player in healthcare transformation? Join us as we engage in a compelling conversation with retired Navy Captain and cardiothoracic surgeon Dr. Hassan Tetteh, a vanguard in clinical informatics and artificial intelligence. We unravel AI's metamorphosis within military and federal healthcare systems, spotlighting its evolution from an unseen assistant to a dynamic co-pilot in the field of medicine. Discover how AI is becoming integral in tasks such as medical note-taking, sepsis detection, and the groundbreaking realm of robotic surgeries, including the historic first fully robotic heart transplant. Our discussion delves deeper into the profound impact of AI on military and Veterans Affairs medicine. Witness how AI is revolutionizing combat zone triage, telemedicine, and damage control resuscitation, offering unprecedented medical support in austere environments. We explore AI's potential to empower medical professionals with virtual platforms and wearable devices, as well as the innovative deployment of life-saving resources via drones. Dr. Tetteh sheds light on how AI is addressing critical issues in the VA system, tackling challenges like suicide, mental health, and traumatic brain injuries, and reshaping healthcare for military personnel and veterans alike. Balancing innovation with caution, we also navigate the ethical and regulatory complexities that accompany the integration of AI into healthcare. Highlighting the strategic collaboration between the Warfighter Health Mission and the VA, we explore how AI and electronic health records leverage data to provide crucial health insights. The conversation highlights the transformative potential of AI while emphasizing the importance of data integrity and the need for ongoing learning among healthcare professionals. As we chart the future of AI in healthcare, this episode serves as both a guide and a clarion call for adaptability and leadership in an age of rapid technological advancement. Episode Support: A generous educational grant from HumanCare Technologies Inc. supported the episode. Chapters: (00:05) AI Impact on Healthcare Transformation (13:12) Advancements in Military and VA Medicine (20:42) Data Privacy and AI in Healthcare (30:25) Military Medicine and AI Impact (37:18) Evolution of Healthcare Roles With AI (52:04) Path to AI Adoption in Healthcare (01:00:17) National Security and AI Chapter Summaries: (00:05) AI Impact on Healthcare Transformation AI is transforming healthcare, aiding in tasks from notes to surgery, and has strategic importance for national security. (13:12) Advancements in Military and VA Medicine AI has transformative potential in military medicine, enhancing care delivery in combat zones and remote settings, and addressing challenges in the VA system. (20:42) Data Privacy and AI in Healthcare AI and electronic health records aid in addressing health challenges for military personnel and veterans, including suicide prevention and improving healthcare delivery. (30:25) Military Medicine and AI Impact AI has transformative potential in healthcare, digitizing and de-identifying pathology slides and utilizing radiologic data for improved patient outcomes. (37:18) Evolution of Healthcare Roles With AI Nature's evolving healthcare professions adapt to AI, emphasizing continuous learning and the role of human decision commanders. (52:04) Path to AI Adoption in Healthcare AI in healthcare: FDA's adaptation, adoption curve, data literacy, upskilling, and transformative potential for efficient solutions. (01:00:17) National Security and AI AI is a transformative technology with global implications, and the US should lead in its development. Take Home Messages: AI as a Co-Pilot in Healthcare: Artificial intelligence is transitioning from an invisible assistant to a critical co-pilot in both military and VA healthcare settings. Its applications range from assisting in robotic surgeries to providing real-time decision support at the bedside, illustrating its potential to enhance medical practices and patient care significantly. Transformative Impact on Military Medicine: AI is revolutionizing military healthcare by improving combat triage, telemedicine, and remote resuscitation. This technology enables life-saving innovations such as drone deployments and advanced wearables, which are crucial in delivering care in challenging environments. AI's Role in Addressing Veterans' Health Challenges: Within the Veterans Affairs system, AI is being leveraged to tackle pressing issues such as mental health challenges, suicide prevention, and traumatic brain injuries. The integration of AI-driven insights from electronic health records is paving the way for improved healthcare delivery and patient outcomes. The Ethical and Regulatory Landscape of AI in Healthcare: As AI continues to integrate into healthcare, it is essential to address ethical considerations and regulatory challenges. Balancing innovation with regulation is crucial to maintaining leadership in AI technology, ensuring data integrity, and fostering continuous learning among healthcare professionals. Evolving Roles in Healthcare Professions: The integration of AI is prompting a shift in healthcare roles, where professionals are evolving into "decision commanders" equipped with enhanced information to make better decisions. This transformation underscores the importance of adaptability and continuous learning to keep pace with technological advancements in the field. Episode Keywords: AI in military healthcare, Dr. Hassan Tetteh, robotic heart transplants, autonomous surgeries, combat triage, telemedicine, veteran mental health, suicide prevention, traumatic brain injuries, Warfighter Health Mission, electronic health records, data privacy in healthcare, ethical AI in medicine, medical decision-making, healthcare technology, AI integration, healthcare innovation, national security and AI, AI advancements in medicine Hashtags: #MilitaryHealthcare #AIRevolution #VeteranWellbeing #AIinMedicine #CombatMedicine #HealthcareInnovation #VAHealthcare #AIFuture #TechInHealthcare #MedicalAdvancements Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation. Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms. Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast